BRIEF-Quest Diagnostics gets FDA emergency use authorization for Zika test
April 28 (Reuters) - Quest Diagnostics Inc :
* Received U.S. FDA emergency use authorization (EUA) for the Zika virus RNA qualitative real-time RT-PCR test
* Plans to make new test broadly available to physicians for patient testing, including in Puerto Rico, early in week of may 2, 2016
* Plans to offer serological testing capabilities that have received EUA from FDA to complement its new molecular zika test service Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.